Amgen, newer rivals could threaten Novo Nordisk and Eli Lilly’s weight loss drug dominance

Amgen, Viking Therapeutics, Altimmune, AstraZeneca, Boehringer Ingelheim and Zealand Pharma are making encouraging progress on their own treatments.